Grant H. Skrepnek, Ph.D., R.Ph.

Professor

Pharmacy Clinical & Admin Sci

Phone (405) 271-6878 x47105

Fax (4050 271-6430

Office CPB 214

Email grant-skrepnek@ouhsc.edu

Summary

I concentrate on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, I focus on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. I am engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.


Research

Dr. Skrepnek concentrates on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, Dr. Skrepnek focuses on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. He is engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.



Publications & Presentations

<< 8 9 10 11 12 13 14 > >>
    51. Altyar A, Bakhsh H T, Mohammed A, Skrepnek G H, Patanwala A E. Administration of first dose antibiotic in the ED in patients with minor skin and soft tissue infections. The American journal of emergency medicine. 2015; 33 : 1225-8

    52. Skrepnek G H, Mills, Sr J L, Armstrong D G. A Diabetic Emergency One Million Feet Long: Disparities and Burdens of Illness among Diabetic Foot Ulcer Cases within Emergency Departments in the United States, 2006-2010. PloS one. 2015; 10 : e0134914

    53. Gilligan A M, Skrepnek G H. Determinants of life expectancy in the Eastern Mediterranean Region. Health policy and planning. 2015; 30 : 624-37

    54. Skrepnek G H, Mills J, Armstrong D. An Emergency One Million Feet Long: Acute Diabetic Foot Ulcers in the US 2006-2010. PLOS One. 2015

    55. Tate W R, Skrepnek G H. Quality-adjusted time without symptoms or toxicity (Q-TWiST): patient-reported outcome or mathematical model? A systematic review in cancer. Psycho-oncology. 2015; 24 : 253-61

<< 8 9 10 11 12 13 14 > >>



Grants

<< 1 2 3 4 >>
    11. Improving the Health of Americans through Prevention and Management of Diabetes, Heart Disease, and Stroke. Non-federal. Start Date: 2019. End Date: 2020.

    12. Allergan (PI: Keast). Federal Non-NIH. Start Date: 2018. End Date: 2019.

    13. Otsuka (Skrepnek/Keast PI). Non-federal. Start Date: 2018. End Date: 2019.

    14. Research Fellowship. PhRMA. Start Date: 2017. End Date: 2018.

    15. Development of a Predictive Model for METAVIR Fibrosis Scores for Patients Chronically Infected with Hepatitis C Virus. Misc Non-Federal. Start Date: 2017.

<< 1 2 3 4 >>



Awards and Honors


no results

Education


no results

Administrative Assignments

                                                
     1. Role: Director. Scope: Department. Date: 2019.
                                                
     2. Role: Director. Scope: Department. Description: Interim Director & Director of Academic Research. Date: 2019.